The company is spinning its patient monitoring and respiratory interventions businesses into a new company. Combined, these businesses generate about $2.2 billion.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,